疏痰能顆粒20公絲/公克(乙基希賜典) Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

疏痰能顆粒20公絲/公克(乙基希賜典)

永豐化學工業股份有限公司 台北縣新莊巿新樹路292號 (03155301) - acetylcysteine - 內服顆粒劑 - acetylcysteine (4800000100) 20mg - 袪痰

安命諾補樂含電解質注射液5% Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

安命諾補樂含電解質注射液5%

臺灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - l-aspartic acid;;lysine l- hcl ( eq to l-lysine hcl);;asparagine l- monohydrate (eq to asparagine h2o l- );;l-phenylalanine;;malic acid l-;;l-tyrosine;;l-arginine;;acetylcysteine;;l-threonine;;l-leucine;;glutamic acid l-;;l-histidine;;l-proline;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate);;l-alanine;;magnesium acetate tetrahydrate;;glycine (eq to aminoacetic acid)(eq to glycocoll);;sodium hydroxide;;l-ornithine hcl;;l-tryptophan;;l-isoleucine;;l-serine;;l-valine;;tyrosine l-(n-acetyl);;l-methionine;;potassium acetate - 注射劑 - potassium acetate (4008000100) 2.45mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) 3.95mg; magnesium acetate tetrahydrate (4012001450) 0.56mg; l-alanine (4020100202) 6.85mg; l-arginine (4020100302) 4.6mg; l-aspartic acid (4020100402) 0.65mg; asparagine l- monohydrate (eq to asparagine h2o l- ) (4020100472) 1.86mg; glutamic acid l- (4020100702) 2.30mg; l-histidine (4020100902) 2.6mg; l-isoleucine (4020101002) 2.55mg; l-leucine (4020101202) 4.45mg; lysine l- hcl ( eq to l-lysine hcl) (4020101312) 3.5mg; l-methionine (4020101502) 1.9mg; l-ornithine hcl (4020101612) 1.60mg; l-phenylalanine (4020101702) 2.55mg; l-proline (4020101802) 4.45mg; l-serine (4020101902) 1.20mg; l-threonine (4020102002) 2.05mg; l-tryptophan (4020102102) 0.9mg; l-tyrosine (4020102202) 0.30mg; l-valine (4020102302) 2.4mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 3.95mg; tyrosine l-(n-acetyl) (4020192212) 0.43mg; acetylcysteine (4800000100) 0.34mg; sodium phosphate monobasic (eq to monosodium phosphate)(eq to sodium dihydrogen phosphate) (5612002610) 1.40mg; malic acid l- (9600017802) 1.01mg; sodium hydroxide (9600028200) 0.20mg - amino acids - 不能攝取適當食物之患者之補助治療劑、蛋白質之消化吸收機能或合成利用障礙、嚴重創傷骨折時蛋白質之補給、蛋白質攝取減少之營養失調症。

腎福諾輸注液 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

腎福諾輸注液

臺灣費森尤斯卡比股份有限公司 台北市大安區仁愛路三段30號5樓32號5樓 (12980985) - l-isoleucine;;l-leucine;;lysine l- (acetate);;l-methionine;;acetylcysteine;;l-phenylalanine;;l-threonine;;l-tryptophan;;l-valine;;arginine;;l-histidine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-alanine;;l-proline;;l-serine;;malic acid l- - 注射劑 - l-alanine (4020100202) 6.30mg; arginine (4020100300) 4.90mg; l-histidine (4020100902) 4.30mg; l-isoleucine (4020101002) 5.10mg; l-leucine (4020101202) 10.30mg; l-methionine (4020101502) 2.80mg; l-phenylalanine (4020101702) 3.80mg; l-proline (4020101802) 4.30mg; l-serine (4020101902) 4.50mg; l-threonine (4020102002) 4.80mg; l-tryptophan (4020102102) 1.90mg; l-valine (4020102302) 6.20mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 3.20mg; lysine l- (acetate) (4020191322) (10.01mg) 7.1mg; acetylcysteine (4800000100) *0.50mg; malic acid l- (9600017802) 1.50mg - amino acids - 不能攝取適當食物之患者之補助治療劑,蛋白質之消化吸收機能或合成利用障礙,嚴重創傷火傷骨折時蛋白質之補給,蛋白質攝取減少之營養失調症

諾你健N靜脈輸注液8% Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

諾你健n靜脈輸注液8%

臺灣費森尤斯卡比股份有限公司 臺北市大安區仁愛路3段30號5樓、32號5樓 (12980985) - l-isoleucine;;l-leucine;;l-lysine acetate;;acetylcysteine;;l-methionine;;l-alanine;;l-phenylalanine;;l-serine;;arginine;;l-histidine;;l-proline;;l-valine;;l-tryptophan;;glycine (eq to aminoacetic acid)(eq to glycocoll);;l-threonine - 注射劑 - l-alanine (4020100202) 4.64mg; arginine (4020100300) 10.72mg; l-histidine (4020100902) 2.8mg; l-isoleucine (4020101002) 10.4mg; l-leucine (4020101202) 13.09mg; l-lysine acetate (4020101322) 9.71mg; l-methionine (4020101502) 1.10mg; l-phenylalanine (4020101702) 0.88mg; l-proline (4020101802) 5.73mg; l-serine (4020101902) 2.24mg; l-threonine (4020102002) 4.40mg; l-tryptophan (4020102102) 0.70mg; l-valine (4020102302) 10.08mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) 5.82mg; acetylcysteine (4800000100) 0.70mg - amino acids - 腸外營養補充劑

乙醯半胱氨酸 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

乙醯半胱氨酸

臺灣必治妥施貴寶股份有限公司 台北市南京東路5段125號7樓 (11922609) - acetylcysteine - (粉) - 主成分 () ; acetylcysteine (4800000100) - ★痰劑

乙醯半胱氨酸 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

乙醯半胱氨酸

春安貿易有限公司 台北巿承德路2段12號6F之1 (11465602) - acetylcysteine - (粉) - 主成分 () ; acetylcysteine (4800000100) 98.0-102.0% - 袪痰劑

乙醯半胱氨酸 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

乙醯半胱氨酸

必美股份有限公司中壢廠 桃園市平鎮區北勢村二鄰關爺東路32號 - acetylcysteine - (粉) - 主成分 () ; acetylcysteine (4800000100) 98-102% - 袪痰劑

富爾糖衣錠250公絲 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

富爾糖衣錠250公絲

南洋產業股份有限公司 台北巿長安東路一段43巷4號 (11492903) - thiamphenicol (glycinate acetylcysteinate);;acetylcysteine (eq to thiamphenical glycinate) - 糖衣錠 - acetylcysteine (eq to thiamphenical glycinate) (0812408220) *(405mg) 115mg; thiamphenicol (glycinate acetylcysteinate) (0812409220) *(405mg) 250mg - 革蘭氏陽性、陰性菌、立克次氏體及巨型濾過性病毒感染症**=TARTRAZINE 36%+ALUMINUM OXIDE 64% *ACETYLCYSTEINE=115MG

喜朗100散 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

喜朗100散

驊茂企業有限公司 台北巿仁愛路三段98號4樓 (09427955) - acetylcysteine - 散劑 - acetylcysteine (4800000100) 100.0mg - 減少呼吸道粘膜分泌的黏稠性。

富味兒顆粒 Ταϊβάν - Κινεζικά - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

富味兒顆粒

南洋產業股份有限公司 台北巿長安東路一段43巷4號 (11492903) - acetylcysteine (eq to thiamphenical glycinate);;thiamphenicol (glycinate acetylcysteinate) - 內服顆粒劑 - acetylcysteine (eq to thiamphenical glycinate) (0812408220) *(4gm) 1.15gm; thiamphenicol (glycinate acetylcysteinate) (0812409220) *(4gm) 2.5gm - 革蘭氏陽性、陰性菌、立克次氏體及巨型濾過性病毒感染症